版本:
中国

BRIEF-Soligenix reports Q1 loss per share $0.32

May 11 Soligenix Inc-

* Soligenix announces recent accomplishments and first quarter 2017 financial results

* Q1 loss per share $0.32

* Q1 revenue $1.3 million versus $2.6 million

* Soligenix - anticipate initiating pivotal phase 3 trial of sgx942, for treatment of oral mucositis in patients with head and neck cancer, in q2 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐